Grappling with the Androgen Receptor: A New Approach for Treating Advanced Prostate Cancer

Cancer Cell

Volumn 17, Issue 6, 2010, Pages 525-526

  Thompson, Timothy C ^a  

^a Department of Genitourinary Medical Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANTINEOPLASTIC AGENT; BICALUTAMIDE; EPI 001; ESTROGEN; FLUTAMIDE; FORSKOLIN; MDV 3100; RU 59063; UNCLASSIFIED DRUG;

ADVANCED CANCER; ANDROGEN DEPRIVATION THERAPY; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CASTRATION; EPIGENETICS; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 77953252473     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2010.05.018     Document Type: Short Survey

References (9)

1. Andersen R.J., Mawji N.R., Wang J., Wang G., Haile S., Myung J.K., Watt K., Tam T., Yang Y.C., Banuelos C.A., et al. Cancer Cell 17 (2010) 535-546 this issue
2. Chen Y., Sawyers C.L., and Scher H.I. Curr. Opin. Pharmacol. 8 (2008) 440-448
3. Huggins C., and Hodges C.V. Cancer Res. 1 (1941) 293-297
4. Nacusi L.P., and Tindall D.J. Expert Rev. Endocrinol. Metab. 4 (2009) 417-422
5. Steinkamp M.P., O'Mahony O.A., Brogley M., Rehman H., Lapensee E.W., Dhanasekaran S., Hofer M.D., Kuefer R., Chinnaiyan A., Rubin M.A., et al. Cancer Res. 69 (2009) 4434-4442
6. Taplin M.E., and Balk S.P. J. Cell. Biochem. 91 (2004) 483-490
7. Tran C., Ouk S., Clegg N.J., Chen Y., Watson P.A., Arora V., Wongvipat J., Smith-Jones P.M., Yoo D., Kwon A., et al. Science 324 (2009) 787-790
8. Van Dort M.E., Robins D.M., and Wayburn B. J. Med. Chem. 43 (2000) 3344-3347
9. Vis A.N., and Schroder F.H. BJU Int. 104 (2009) 438-448